Radiation in vulvar cancer

Area of Science:

• Gynecologic Oncology
• Radiation Oncology
• Medical Oncology

Background:

• Vulvar cancer is a rare gynecological malignancy primarily affecting elderly women.
• Limited literature and scarcity of prospective trials complicate treatment guidelines for vulvar cancer.
• Radiation therapy is a key treatment modality, but its role requires further definition.

Purpose of the Study:

• To review recent literature on the role of radiation therapy in managing vulvar cancer.
• To discuss current treatment strategies and emerging options for vulvar cancer patients.

Main Methods:

• A comprehensive review of recent scientific literature was conducted.
• Analysis focused on studies addressing radiation therapy and chemoradiotherapy in vulvar cancer management.
• Retrospective studies form the majority of available evidence due to the rarity of the disease.

Main Results:

• Combined chemoradiotherapy (CCRT) shows promise for locally advanced vulvar cancer (LAVC), potentially reducing surgical morbidity.
• Concurrent chemoradiotherapy (CCRT) trials using agents like cisplatin, 5-fluorouracil, and mitomycin-C have yielded encouraging outcomes.
• Radiation therapy maintains an adjuvant role in early-stage vulvar cancer.

Conclusions:

• CCRT is an emerging feasible option for LAVC, serving as both preoperative and definitive treatment.
• Radiation therapy continues to be an important adjuvant treatment for early-stage vulvar cancer.
• Future research should explore advanced radiation techniques like intensity-modulated radiation therapy to minimize treatment-related toxicity.